The company’s officials expect the new segment to bring 10% of its turnover by 2030.
“Today, Antibiotice launches a new business line, the veterinary supplements range, under the VetAria umbrella brand according to the business plan “The Future Together”. Our intention is to bring innovation in the pharmaceutical industry and market landscape. We take an important step between tradition and modernism, we start a new, innovative path, part of the current stage of portfolio modernization and fruition of a potential in new markets, with consolidated partnerships and new products,” said Ovidiu Bățaga, Executive Director – National Sales Unit, Antibiotice Iași.
VetAria+ includes eight products manufactured on GMP authorized manufacturing flows (Good Manufacturing Practice), whose composition is unique in the Romanian market, containing ingredients with optimal therapeutic effects both in the prevention and improvement of symptoms specific to the pathologies for which they are intended.
Antibiotice aims, by 2030, to boost its portfolio of vet products to meed the rising demand for pet care products.
(English version by Catalina Apostoiu)